Natera Investors

15 investors on Angel Roster list Natera in their portfolio. Most are venture capital firms and hedge funds, the most common stage is Seed and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Natera can appear together.

Investors listed
15
With verified email
53%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Natera investors

The most complete profiles first. Showing 15 of 15.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Andrew ChungVerified

    Venture Capital · United States

    Education

    Portfolio: CoalTek, Stion, EcoMotors, LanzaTech and 12 more

    Verified email available

  • Brad WebbVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsE-commerce

    Portfolio: Arcxis Biotechnologies, Tibion Bionic Technologies, Root3 Technologies, Comfy and 30 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Paul StraubVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsE-commerce

    Portfolio: Arcxis Biotechnologies, Tibion Bionic Technologies, Root3 Technologies, Comfy and 30 more

    Verified email available

  • Adms Chung

    Angel/Individual · United States

    SeedHealth CareWearablesE-commerceMessaging

    Portfolio: Gridtential Energy, Personalis, MoBagel, BioConsortia and 6 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Randy Hawks

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsE-commerce

    Portfolio: Arcxis Biotechnologies, Tibion Bionic Technologies, Root3 Technologies, Comfy and 30 more

    Contact details available

  • Michael Mashaal

    Investment Bank · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Corindus, Claret Medical, CareView Communications, Ikena Oncology and 3 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Natera investors are on Angel Roster?

Angel Roster lists 15 Natera investors. 8 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (13), Hedge Funds (2) and Private Equity Firms (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Natera investors invest in?

Among those that list a stage, the most common are Seed (5) and Series B (1).

Where are Natera investors based?

Most are based in the United States (14) and Canada (1).

Which companies have Natera investors backed?

The most-backed portfolio companies among them are InCarda Therapeutics (9), AFYX Therapeutics (9), Gyroscope Therapeutics (9), NuCana BioMed (9) and Promedior (9).

How do I contact Natera investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.